New drugs under development for COPD. (2022)
Attributed to:
'COVAIR': Is SARS-CoV-2 airborne and does it interact with particle pollutants?
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.23736/s0026-4806.22.08024-7
PubMed Identifier: 35142480
Publication URI: http://europepmc.org/abstract/MED/35142480
Type: Journal Article/Review
Volume: 113
Parent Publication: Minerva medica
Issue: 3
ISSN: 0026-4806